Articles published by Atara Biotherapeutics, Inc.
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2022
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
August 03, 2022
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
August 01, 2022
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
April 28, 2022
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics Provides Update on ATA2271 Autologous CAR T Trial
February 18, 2022
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 07, 2022
Via Business Wire
Tickers
ATRA
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2022
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022
Via Business Wire
Tickers
ATRA
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2021
Via Business Wire
Tickers
ATRA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.